Syros Pharmaceuticals, Inc. stock forum
SYRS: A groundbreaking leader in gene control therapies. At just $0.20, the potential upside is extraordinary. Analysts see (SYRS) reaching $10.50 soon, from just $0.20 today.
Sometimes, the best opportunities are the ones right in front of you.